Conceptio
›
car-t-cells
Topic
car-t-cells
Knowledge-graph topic
· documents ABOUT car-t-cells across the archive
32
Documents about car-t-cells
Documents about car-t-cells
GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG)
#181750
ClinicalTrials.gov
Clinical Study of PSMA-targeted CAR-T Cells in the Treatment of Castration-resistant Prostate Cancer
#356464
ClinicalTrials.gov
A soluble bi-specific fusion protein for the improved expansion of human CD8+ CAR-T cells
#379857
bioRxiv / medRxiv
Targeting CD19 and CD22 CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory B Cell Lymphoma
#451461
ClinicalTrials.gov
CD19/20 Bispecific Nanobody-derived CAR-T Cells in B Cell Lymphoma
#877348
ClinicalTrials.gov
huCART19-IL18 in CD19+ Cancers
#880694
ClinicalTrials.gov
HER2 Targeted HypoSti.CAR-T Cells in HER2 Positive Advanced Solid Tumors
#1033516
ClinicalTrials.gov
CAR T-cells Against CD30 (HSP-CAR30) for Relapsed/ Refractory Hodgkin and T-cell Lymphoma.
#140998
ClinicalTrials.gov
CAR2219 CAR-T Cells for the Treatment of R/R B Cell Leukemia and Lymphoma
#1032395
ClinicalTrials.gov
Bispecific CAR T Cells for B-cell Malignancies (BaseCAR-01 Trial)
#835765
ClinicalTrials.gov
Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas
#868016
ClinicalTrials.gov
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
#876910
ClinicalTrials.gov
Response to Chimeric Antigen Receptor (CAR)-T Cells Therapy in Patients With Hematologic Malignancies Depending on Tumor Characteristics
#208430
ClinicalTrials.gov
Study Evaluating Safety and Efficacy of CAR-T Cells Targeting CD123 in Patients With Acute Myelocytic Leukemia
#411380
ClinicalTrials.gov
CTLA-4 and PD-1 Antibodies Expressing EGFR-CAR-T Cells for EGFR Positive Advanced Solid Tumor
#481751
ClinicalTrials.gov
CAR-T Cells Therapy for Patients With Autoimmune Diseases
#849048
ClinicalTrials.gov
A Study of CAR T-Cells in Relapsed/Refractory Hematologic Malignancy
#856066
ClinicalTrials.gov
TGFβR-KO CAR-EGFR T Cells in Previously Treated Advanced EGFR-positive Solid Tumors
#895122
ClinicalTrials.gov
Targeting CD19 and BCMA CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory Multiple Myeloma
#915975
ClinicalTrials.gov
A Phase II Study to Evaluate the Efficacy of UF-KURE19 Cells in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas
#856853
ClinicalTrials.gov
Study of 19(T2)28z1xx TRAC-Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Lymphoma
#857900
ClinicalTrials.gov
Study of CD4-Targeted Chimeric Antigen Receptor T-Cells (CD4- CAR-T) in Subjects With Relapsed or Refractory T-Cell Lymphoma
#1009395
ClinicalTrials.gov
Mesothelin-targeted CAR-T Cells as a Neo-adjuvant Treatment in Patients With Resectable Pancreatic Cancers: a Feasibility Study
#143674
ClinicalTrials.gov
A Study on the Safety, Preliminary Efficacy, and Cellular Kinetics of Allo-CD7 CAR-T Cells in T1DM
#152575
ClinicalTrials.gov
CAR-T Cells Combined With Peptide Specific Dendritic Cell in Relapsed/Refractory Leukemia/MDS
#160346
ClinicalTrials.gov
CAR T cell therapy selectively depletes disease-driving mutant calreticulin cells in xenotransplants and human organoid models of myelofibrosis
#273159
Europe PMC
GPC2 CAR T Cells for Relapsed or Refractory Neuroblastoma and Metastatic Retinoblastoma
#303733
ClinicalTrials.gov
A Clinical Research of CAR T Cells Targeting CEA Positive Colorectal Cancer (CRC)
#801249
ClinicalTrials.gov
Safety and Efficacy Evaluation of IM83 CAR-T Cells for Patients With Advanced Liver Tumors
#830965
ClinicalTrials.gov
Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma
#851887
ClinicalTrials.gov
Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
#915404
ClinicalTrials.gov
Targeting CD19 and CD22 CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory Acute B Lymphocytic Leukemia
#28330
ClinicalTrials.gov
Synergistic Antitumor Efficacy of Radiofrequency Ablation Combined With TROP2-CAR-T Cells in a Xenograft Mouse Model of Lung Adenocarcinoma.
#157031
NCBI PubMed Central
Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells
#226260
ClinicalTrials.gov
Breaking the resistance barrier: synergistic evolution of CAR-T cells and bispecific antibodies in the era of precision immuno-oncology.
#371522
NCBI PubMed Central
Safety and Efficacy of IM21 Car-t Cells in Patients With Recurrent or Refractory BCMA Positive Multiple Myeloma
#967446
ClinicalTrials.gov
Clinical Trial of SL1904B CAR-T Cells for Relapsed or Refractory Non-Hodgkin Lymphoma
#1031381
ClinicalTrials.gov
Efficacy and Safety of TKI Combined With Chemotherapy and Sequential CAR-T Cells in ND Adult Patients With Ph+ ALL
#1010889
ClinicalTrials.gov
BCMA Nano Antibody CAR-T Cells for Patients With Refractory and Relapsed Multiple Myeloma
#827806
ClinicalTrials.gov
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
#839456
ClinicalTrials.gov
Dual Anti-CD22/CD19 Chimeric Antigen Receptor-directed T Cells (CART2219.1) for Relapsed Refractory B-Lineage Leukaemia
#968677
ClinicalTrials.gov
Controlling Hyperactive Immunity With Long-lived Lymphocytes
#981396
ClinicalTrials.gov
Sequential Infusion of Anti-CD19 and Anti-CD20 CAR-T Cells Against Relapsed and Refractory B-cell Lymphoma
#140978
ClinicalTrials.gov
Mathematical modeling and sensitivity analysis of synNotch-CAR T-cells identify engineering targets for dynamic tunability
#149900
Unpaywall
C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
#267996
ClinicalTrials.gov
Safety and Efficacy of ALLO-715 BCMA Allogenic CAR T Cells in in Adults With Relapsed or Refractory Multiple Myeloma (UNIVERSAL)
#865765
ClinicalTrials.gov
Clinical Study of SL19+22 CAR-T Cells for Relapsed or Refractory Non-Hodgkin Lymphoma
#914570
ClinicalTrials.gov
Study of Welgenaleucel (UWC19) in Patients With Relapsed or Refractory B-cell Lymphoma
#915980
ClinicalTrials.gov
CD30 CAR for CD30+ NSGCT
#1008049
ClinicalTrials.gov
19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers
#826141
ClinicalTrials.gov
← Previous
Page 4 of 6
Next →
Topic record
· derived from the Conceptio knowledge graph (shared subject terms across the corpus)
Conceptio Open Knowledge Archive — topic hubs link to canonical document pages with full provenance.